| Status | Finished |
|---|---|
| Effective start/end date | 3/1/96 → 3/31/09 |
Funding
- National Institutes of Health: $372,400.00
- National Institutes of Health: $412,900.00
- National Institutes of Health: $469,203.00
- National Institutes of Health
- National Institutes of Health: $377,500.00
- National Institutes of Health: $418,421.00
- National Institutes of Health: $377,500.00
- National Institutes of Health
- National Institutes of Health
- National Institutes of Health: $377,500.00
- National Institutes of Health: $377,500.00
- National Institutes of Health: $417,956.00
- National Institutes of Health
Fingerprint
Cytomegalovirus
Histocompatibility Antigens Class II
Histocompatibility Antigens Class I
Simplexvirus
Cytomegalovirus Retinitis
Antigen Presentation
Viruses
T-Lymphocytes
Retinitis
Acquired Immunodeficiency Syndrome
HIV
Virus Diseases
Cellular Immunity
Proteins
Immune Evasion
Highly Active Antiretroviral Therapy
Bone Marrow
Antigens
Virus Latency
Quality of Life
ASJC
- Medicine(all)